Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care As Usual Only
Digital Monitoring With Patient-Reported Outcomes in Cancer Care: A Randomized Controlled Trial RC - 102 (Resilience Care - 102)
Resilience
1,458 participants
Apr 1, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to learn if Resilience PRO, a digital solution performing remote symptoms monitoring, can improve the quality of life of patients with a diagnosis of cancer receiving systemic anticancer treatment. The main question it aims to answer is: \- Do patients with a diagnosis of cancer receiving systemic anticancer therapy and using Resilience PRO have an improved quality of life? Researchers will compare patients using Resilience PRO plus care as usual to patients receiving care as usual only. Participants in the intervention arm will use Resilience PRO, a mobile phone application regularly asking participants about their symptoms. For clinically important symptoms, an alert is sent to the care team that can incorporate that information to timely adjust the care of the participants. Participants both in the control arm and in the intervention arm will further receive care as usual.
Eligibility
Inclusion Criteria6
- Age: Adults ≥ 18 years.
- Informed Consent: Patient giving signed informed consent to participate in the RC - 102 clinical study.
- Diagnosis: Patients with cancer at any stage.
- Systemic Treatment
- Remote Monitoring Eligibility: Access to a smartphone
- Language: Ability to understand and communicate in the language(s) in which the trial is conducted.
Exclusion Criteria7
- Age: Patients under 18 years of age.
- Life Expectancy: Patients with a life expectancy of less than 6 months as estimated by the treating physician.
- Concurrent remote monitoring
- HSCT or CAR-T Therapy
- Cognitive Impairment
- Pregnancy or breastfeeding
- Subject under administrative or judicial control
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The patient will use Resilience PRO remote symptoms monitoring.
Locations(36)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06867705